Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antagonists for toxic heavy metals.

M M Jones

    Proceedings of the Western Pharmacology Society
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Identifying effective chelating agents for toxic metal poisoning requires matching metal donor preferences with chelator acceptor preferences. Cellular location and rapid excretion are crucial for successful toxic metal antagonism.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Semipermeable species boundaries create opportunities for gene flow and adaptive potential.

    Molecular ecology·2023
    Same author

    [Morphological changes in rabbit cornea after implantation of a new keratoprosthesis supporting plate].

    Vestnik oftalmologii·2020
    Same author

    The C-terminal region of the major outer sheath protein of Treponema denticola inhibits neutrophil chemotaxis.

    Molecular oral microbiology·2017
    Same author

    Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

    Leukemia·2017
    Same author

    Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

    Leukemia·2016
    Same author

    Sampling Methods for Detection and Monitoring of the Asian Citrus Psyllid (Hemiptera: Psyllidae).

    Environmental entomology·2015
    Same journal

    Ageing, health and medication consumption in a sample of academic employees at a Mexican university.

    Proceedings of the Western Pharmacology Society·2012
    Same journal

    Treatment with LA-419 prevents monocrotaline-induced pulmonary hypertension and lung injury in the rat.

    Proceedings of the Western Pharmacology Society·2012
    Same journal

    Valproic acid modulates brain plasticity through epigenetic chromatin remodeling in the blind rat: implications for human sight recovery.

    Proceedings of the Western Pharmacology Society·2012
    Same journal

    Calmodulin antagonists inhibit sea urchin sperm hyperpolarization necessary for directed movement toward the egg.

    Proceedings of the Western Pharmacology Society·2012
    Same journal

    Ganoderma lucidum reduces kainic acid-induced hippocampal neuronal damage via inflammatory cytokines and glial fibrillary acid protein expression.

    Proceedings of the Western Pharmacology Society·2012
    Same journal

    Effect of orlistat on lipid peroxidation, Na+, K+ ATPase, glutathione and serotonin in rat brain.

    Proceedings of the Western Pharmacology Society·2012
    See all related articles

    Area of Science:

    • Toxicology
    • Pharmacology
    • Biochemistry

    Background:

    • Toxic metals pose health risks, necessitating effective therapeutic interventions.
    • Chelating agents are used to treat metal poisoning by binding to and removing toxic metals.
    • Understanding metal-ligand interactions is key to developing new antidotes.

    Purpose of the Study:

    • To explore the principles for selecting effective chelating agents against toxic metals.
    • To identify factors limiting the efficacy of chelating agents in vivo.
    • To define characteristics of ideal chelating agents for toxic metal antagonism.

    Main Methods:

    • Analysis of donor-acceptor preferences of toxic metals and chelating agents.
    • Consideration of metal distribution (extracellular vs. intracellular).

    Related Experiment Videos

  • Evaluation of complex stability, toxicity, and excretion pathways.

    • Main Results:

    • Chelating agent efficacy depends on matching metal donor and chelator acceptor properties.
    • Intracellular metal location can limit the effectiveness of chelating agents.
    • Ideal chelating agents form stable, low-toxicity complexes that are rapidly excreted without organ damage.

    Conclusions:

    • Rational selection of chelating agents can be based on donor-acceptor principles.
    • Factors like metal compartmentalization and pharmacokinetic properties are critical for therapeutic success.
    • Effective antagonists are not available for all toxic metals, highlighting the need for further research.